| AUC | area under the curve |
| BC | breast cancer |
| CAF | cancer-associated fibroblast |
| Cancer_Malig | cancer malignant cell |
| CCI | Cell-cell interaction |
| CD4+T | CD4+ T lymphocytes |
| CD8+T | CD8+ T lymphocytes |
| cDC | conventional DC |
| CRC | colorectal cancer |
| DC | dendritic cell |
| DEGs | differentially expressed genes |
| ECM | extracellular matrix |
| EMT | epithelial-to-mesenchymal transition |
| End | endothelial cells |
| ESCA | esophageal cancer |
| GIST | gastrointestinal stromal tumor |
| KM | Kaplan–Meier |
| LC | lung cancer |
| L-R | ligand–receptor |
| Macro | macrophage |
| myCAF | myofibroblast |
| NK | natural killer |
| OV | ovarian cancer |
| PC | principal component |
| PDAC | pancreatic ductal adenocarcinoma |
| pEMT | partial epithelial-to-mesenchymal transition |
| RCC | renal cell carcinoma |
| ROC | receiver operating characteristic |
| scRNA | single-cell RNA |
| ssGSEA | single sample gene set enrichment analysis |
| ST | spatial transcriptome |
| subTME | tumor microenvironment subtype |
| subTME-ICI | immune cell infiltration tumor microenvironment subtype |
| subTME-IS | immune-suppressive tumor microenvironment subtype |
| subTME-MRM | matrix remodeling with malignant cells tumor microenvironment subtype |
| subTME-PSE | precancerous state of epithelial cells tumor microenvironment subtype |
| TAM | tumor-associated macrophage |
| Teff | T lymphocyte effector |
| Tex | T lymphocyte exhaustion |
| TME | tumor microenvironment |
| Treg | T regulatory |